SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-24-129331
Filing Date
2024-05-02
Accepted
2024-05-02 15:52:58
Documents
8
Period of Report
2024-05-02

Document Format Files

Seq Description Document Type Size
1 6-K d793882d6k.htm 6-K 10577
2 EX-99.1 d793882dex991.htm EX-99.1 23274
3 EX-99.2 d793882dex992.htm EX-99.2 21587
4 EX-99.3 d793882dex993.htm EX-99.3 10909
5 EX-99.4 d793882dex994.htm EX-99.4 42725
6 GRAPHIC g793882g0502053257638.jpg GRAPHIC 2601
7 GRAPHIC g793882g0502053401168.jpg GRAPHIC 2601
8 GRAPHIC g793882g86v74.jpg GRAPHIC 1838
  Complete submission text file 0001193125-24-129331.txt   120440
Mailing Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017
Business Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

IRS No.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31368 | Film No.: 24907914
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)